GE Awarded up to $422.81M Contract; Primerica, CRISPR, Cineverse and Corning: PT Hiked
- June 10th, 2023
- 353 views
General Electric Company's (NYSE: GE) subsidiary, GE Aerospace, has secured a significant contract from the Defense Logistics Agency Aviation for supplies related to the F-series engines (F101/110/118).
The firm-fixed price, requirements-type contract has a maximum value of $422,810,759 and spans over a five-year base period with the potential for an additional five-year option period.
On Friday, $GE closed at $106.30, showing a slight increase of $0.23 (+0.22%)
Primerica, Inc. (NYSE: PRI), a leading provider of financial services, has received an upward revision in its price target from Keefe, Bruyette & Woods, increasing it from $195 to $202.
Based on Friday's closing price of $192.57, this adjusted price target implies a potential upside of approximately $9.43 or around 4.89% for $PRI, as per the view of Keefe, Bruyette & Woods.
CRISPR Therapeutics AG (Nasdaq: CRSP), a renowned biotechnology company specializing in gene-editing technology, has witnessed a price target raise from Needham, elevating it from $82 to $88.
With $CRSP closing at $61.24 on Friday, this adjusted price target indicates a potential upside of approximately $26.76 or around 43.70%, based on Needham's analysis.
Cineverse Corp. (Nasdaq: CNVS), a technology company offering cutting-edge audio and visual solutions, has received an increased price target of $9 from Benchmark, up from $5.
Considering the closing price of $4.04 on Friday, this adjusted price target suggests a potential upside of approximately $4.96 or around 122.77% for $CNVS, as per Benchmark's view.
Corning Incorporated (NYSE: GLW), a global leader in materials science innovation, has been upgraded from Equal-Weight to Overweight by Morgan Stanley, while the price target has been raised from $35 to $38.
With $GLW closing at $32.78 on Friday, this adjusted price target implies a potential upside of approximately $5.22 or around 15.92%, according to Morgan Stanley's analysis.
Please note that the potential upside mentioned for each company is based on the assessment of the respective brokerage firm, investment firm, or analysts. It is crucial for investors to conduct their own research, consider additional factors, and exercise due diligence before making any investment decisions.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025




Member Login